<ul>
<li>Goldman Sachs lifted its total voting rights position in Evotec to 12.42% from 11.18%, crossing the threshold on May 14, 2026.     *      The holding via instruments rose to 12.37% from 9.71%.     *      Voting rights attached to shares fell to 0.05% from 1.47%. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evotec SE published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2331798_en) on May 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</li>
</ul>

GS-D

GS-A

<p>Goldman Sachs has increased its voting rights in Evotec to 12.42% from 11.18%, effective May 14, 2026. The holding via instruments rose to 12.37%, while voting rights attached to shares decreased to 0.05%.</p>

PUBT

Evotec SE

GOLDMAN SACHS GROUP INC DEP REP 1/1000TH PRF D

GOLDMAN SACHS GROUP INC DEP SHR REP 1/1000TH PFD SER A

GOLDMAN SACHS GROUP INC DEP SHS REPSTG 1/1000TH PRF SER C

Goldman Sachs

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

GS Hldg R

Goldman Sachs lifts Evotec voting rights to 12.42% from 11.18%